Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes – (Intravitreal aflibercept for neovascular age-related macular degeneration in patients aged 90 years or older: 2-year visual acuity outcomes, Published online: 2018-06-04; | doi:10.1038/s41433-018-0114-3)

4 June 2018

This news item is available to RCOphth members only, please log in below to access.